571 results on '"Hagenacker, Tim"'
Search Results
2. Effectiveness of Nusinersen in Adolescents and Adults with Spinal Muscular Atrophy: Systematic Review and Meta-analysis
3. Fatigue and associated factors in myasthenia gravis: a nationwide registry study
4. Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison
5. 5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2
6. Oral functions in adult persons with spinal muscular atrophy compared to a healthy control group: a prospective cross-sectional study with a multimodal approach
7. Patients’ and caregivers’ perception of multidimensional and palliative care in amyotrophic lateral sclerosis – protocol of a German multicentre study
8. Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment
9. Versorgung von Patienten mit kardialer Amyloidose: Konsensuspapier der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK), AG 40 Onkologische Kardiologie, und der Deutschen Gesellschaft für Hämatologie und medizinische Onkologie e. V. (DGHO), der Deutschen Gesellschaft für Neurologie e. V. (DGN) und der Deutschen Gesellschaft für Nephrologie e. V. (DGfN)
10. Alteration of LARGE1 abundance in patients and a mouse model of 5q-associated spinal muscular atrophy
11. Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany
12. Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case Report
13. Benign peripheral nerve sheath tumors: an interdisciplinary diagnostic and therapeutic challenge
14. Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy
15. Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
16. Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program
17. Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis
18. Update zur medikamentösen Behandlung der spinalen Muskelatrophie
19. Radiation dose and fluoroscopy time of aneurysm coiling in patients with unruptured and ruptured intracranial aneurysms as a function of aneurysm size, location, and patient age
20. Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
21. „Essener Transitionsmodell“ bei neuromuskulären Erkrankungen
22. Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis
23. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
24. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
25. Zunehmende Schwäche beim Treppensteigen
26. Clinical implications of genetic interphase fluorescence in situ hybridization aberrations in systemic light chain amyloidosis
27. Prevalence and predictors of neurological manifestations in systemic AL amyloidosis
28. 18F-flutemetamol positron emission tomography in cardiac amyloidosis
29. Radiation Exposure During Diagnostic and Therapeutic Angiography of Carotid-cavernous Fistula: A Retrospective Single Center Observational Study
30. Essen transition model for neuromuscular diseases
31. Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany
32. Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany
33. Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study
34. Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients
35. A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case report
36. ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale
37. Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parameters
38. Gene replacement therapy in spinal muscular atrophy: filling the data gaps
39. Immunotherapies in chronic adhesive arachnoiditis - A case series and literature review
40. Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literature
41. Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy
42. Smartphone-Based Assessment of Mobility and Manual Dexterity in Adult People with Spinal Muscular Atrophy
43. Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist
44. Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study
45. Versorgung von Patienten mit kardialer Amyloidose
46. Assessing the extent of symptom control provided by ravulizumab or efgartigimod in generalised myasthenia gravis
47. Post-ischemic triiodothyronine treatment improves stroke outcome by stabilizing the blood-brain barrier
48. Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies
49. Compromised Hippocampal Neuroplasticity in the Interferon-α and Toll-like Receptor-3 Activation-Induced Mouse Depression Model
50. Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.